KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.
| Image |  |
|---|---|
| Description | scientific article published on 29 May 2018 |
| Author/s |
author: Pasquale Pisapia Umberto Malapelle |
| Publication date | May 29, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |